Cargando…

OTHR-37. Pediatrics Cutaneous Reactions in Patient Treated with the Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase Inhibitor Trametinib

OBJECTIVE: To describe the cutaneous adverse effects (AE) to MAPK Extracellular Signal-Regulated Kinase (MEK) Inhibitor Trametinib in the pediatric population. METHODS: This was a retrospective single-center study. Included were all pediatric patients, treated with trametinib, for an oncologic indic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gluck, Mirit, Ben-amitai, Dan, Friedland, Rivka, Toledano, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Others (Not Fitting Any Other Category)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164969/ http://dx.doi.org/10.1093/neuonc/noac079.575

Ejemplares similares

OTHR-13. Effectivity and toxicity of off-label treatment with Trametinib monotherapy or in combination with Dabrafenib in children with relapsed or refractory brain tumor
por: Bregonje, S (Selena), et al.
Publicado: (2022)

OTHR-39. Extraneural spreading of a diffuse leptomeningeal glioneuronal tumor in a child: patient-derived models show sensitivity to vinblastin and trametinib
por: Messiaen, Julie, et al.
Publicado: (2022)

OTHR-18. A pilot study evaluating the access, utilization, and patient satisfaction of basic skin care products among pediatric patients prescribed medications that target the mitogen-activated protein kinase pathway
por: Meyer, Ashley, et al.
Publicado: (2022)

OTHR-09. The prevalence and complex management of MEK inhibitor induced cutaneous side effects
por: Meyer, Ashley, et al.
Publicado: (2022)

OTHR-10. Pilocytic astrocytoma with respect to treatment
por: Hwee Tang, Phua, et al.
Publicado: (2022)

OTHR-14. DIENCEPHALIC SYNDROME SECONDARY TO PITUITARY STALK THICKENING
por: Almeida, Carlos, et al.
Publicado: (2020)

OTHR-17. Guidance for providing families with autopsy research results
por: Meyer, Ashley, et al.
Publicado: (2022)

OTHR-16. CONCURRENT USE OF APREPITANT AND IFOSFAMIDE IN PEDIATRIC CANCER PATIENTS
por: Winzent, Shelby, et al.
Publicado: (2020)

OTHR-38. The development of patient-derived models of pediatric brain tumors
por: Messiaen, Julie, et al.
Publicado: (2022)

OTHR-12. ANEURYSMAL BONE CYST RESEMBLING A POSTERIOR FOSSA TUMOR
por: Navarro, Luis Angel Arredondo, et al.
Publicado: (2020)

OTHR-07. A new framework for missing value tolerant data integration
por: Voß, Hannah, et al.
Publicado: (2022)

OTHR-15. Papillary tumor of the pineal region: case series of this rare pediatric entity
por: Shatara, Margaret, et al.
Publicado: (2022)

OTHR-16. Nutritional screening of U.S. pediatric central nervous system tumor survivors
por: Soja, Jacqueline, et al.
Publicado: (2022)

OTHR-46. Single institution experience using molecular analysis of pediatric CNS tumors
por: Bendel, Anne, et al.
Publicado: (2022)

OTHR-02. MULTIMODALITY TREATMENT FOR CHILDREN WITH CENTRAL NERVOUS SYSTEM (CNS) TUMOR IN OUR INSTITUTE
por: Sasano, Mari, et al.
Publicado: (2020)

OTHR-09. CENTRAL DIABETES INSIPIDUS: A RARE UNREPORTED SIDE EFFECT OF TEMOZOLOMIDE IN PEDIATRICS
por: Kuo, Christopher, et al.
Publicado: (2020)

OTHR-40. DICER 1- a rare , but important tumor driver in malignant progressive brain tumors
por: Fried, Iris, et al.
Publicado: (2022)

OTHR-12. Incidentalomas; should benign, indeterminate MRI findings be discussed at the paediatric neuro-oncology MDT
por: Large, Alexandra, et al.
Publicado: (2022)

OTHR-42. Missing data tolerant integration of proteomic datasets enables the identification and characterization of brain cancer subtypes
por: Voss, Hannah, et al.
Publicado: (2022)

OTHR-20. Precision neuro-oncology in the real world. Opportunity and challenges from a UK Oncology Centre
por: Apps, John, et al.
Publicado: (2022)

OTHR-11. The effects of the COVID-19 Pandemic on the time to diagnosis in pediatric patients with Primary central nervous system tumors
por: Canova, Tyler, et al.
Publicado: (2022)

OTHR-14. Responding to the COVID Challenge: evaluating a new method of adverse event recording in response to remote working.
por: Reiners, Stephanie, et al.
Publicado: (2022)

OTHR-45. Kids First Variant WorkBench: application to germline genomic discoveries in the Children's Brain Tumor Network
por: Guo, Yiran, et al.
Publicado: (2022)

OTHR-35. Health-Related Quality of Life and Social Determinants of Health within Children with Brain and Spinal Cord Tumors
por: Knight, Kelsey, et al.
Publicado: (2022)

OTHR-07. CHRONIC ENCEPHALOPATHY DUE TO METHOTREXATE NEUROTOXICITY AS A RARE COMPLICATION IN A CHILD WITH LEUKEMIA: A CASE REPORT
por: Rafli, Achmad, et al.
Publicado: (2020)

OTHR-43. Composition of cell-free miRNA in cerebrospinal fluid and plasma as a monitoring tool for pediatric brain tumors
por: Anne, Coyle, et al.
Publicado: (2022)

OTHR-02. CHIMERIC AURORA A KINASE (AURKA) DEGRADERS EFFICIENTLY TARGET N-MYC
por: Valinciute, Gintvile, et al.
Publicado: (2023)

OTHR-06. Knowledge gap among health care providers in childhood central nervous system tumors: Result from an international multicenter survey
por: Rajagopal, Revathi, et al.
Publicado: (2022)

OTHR-41. Amplification of the PLAG family genes – PLAGL1 and PLAGL2 – is a key feature of a novel embryonal CNS tumor type
por: Keck, Michaela-Kristina, et al.
Publicado: (2022)

OTHR-08. Pediatric Neurologic Assessment in Neuro-oncology (pNANO) Scale: A tool to assess neurologic function for Response Assessment in Neuro-oncology (RAPNO)
por: Malbari, Fatema, et al.
Publicado: (2022)

OTHR-44. Building narrative competence on the neuro-oncology team: a narrative medicine approach to fostering unity and resilience for work with pediatric brain tumor families
por: Riley, Kathy
Publicado: (2022)

OTHR-36. Management of Central Diabetes Insipidus (CDI) with Low-Dose Vasopressin Infusion in Patients with Non-Germinomatous Germ Cell Tumors (NGGCT) Requiring Hyperhydration during Chemotherapy
por: Fitzgerald, Caroline, et al.
Publicado: (2022)

OTHR-06. NARRATIVE MEDICINE AND THE PRACTICE OF PEDIATRIC NEURO-ONCOLOGY: GRAPPLING WITH THE UNTHINKABLE
por: Riley, Kathy, et al.
Publicado: (2023)

OTHR-11. THE IMPORTANCE AND INFLUENCE OF PATIENT FAMILY INVOLVEMENT IN PEDIATRIC NEURO-ONCOLOGY RESEARCH
por: Lyons, Nicole, et al.
Publicado: (2023)

OTHR-07. CIRCULATING MIRNAS AS A NON-INVASIVE MONITORING TOOL FOR PEDIATRIC BRAIN TUMORS
por: Coyle, Anne, et al.
Publicado: (2023)

OTHR-03. CLASSIFICATION OF BRAIN TUMORS BY NANOPORE SEQUENCING OF CELL-FREE DNA FROM CEREBROSPINAL FLUID
por: Afflerbach, Ann-Kristin, et al.
Publicado: (2023)

OTHR-05. A LIVING EX VIVO PLATFORM FOR FUNCTIONAL, PERSONALIZED PEDIATRIC BRAIN CANCER DIAGNOSIS
por: Mann, Breanna, et al.
Publicado: (2023)

OTHR-01. SUCCESSFUL DEVELOPMENT OF A LOCAL-REGIONAL POST-MORTEM BRAIN TUMOR DONATION PROGRAM
por: Mark, Melissa, et al.
Publicado: (2023)

OTHR-10. COLLABORATIVE EFFORTS FOR HOSPITAL-BASED BIOBANK DEVELOPMENT AND OPTIMIZATION TO ENSURE QUALITY PEDIATRIC SPECIMENS FOR TRANSLATIONAL RESEARCH
por: Lebert, Brittany, et al.
Publicado: (2023)

OTHR-09. A RETROSPECTIVE COHORT STUDY EXAMINING RADIOLOGIC AND CLINICAL CHARACTERISTICS OF CHILDREN AND ADOLESCENTS WITH ATYPICAL/COMPLEX PINEAL CYSTS
por: Tahbaz, Meghan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m7rvihht895qrlv03tpgiodk9q